BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23254496)

  • 21. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
    Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic burden of influenza in the Republic of Korea, 2007-2010.
    Suh M; Kang DR; Lee DH; Choi YJ; Tchoe B; Nam CM; Kim HJ; Lee JK; Jun BY; Youm Y; Bae GN; Lee TY; Kim MS; Shin DC; Kim C
    PLoS One; 2013; 8(12):e84121. PubMed ID: 24386339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of border closure for a generic severe pandemic threat using New Zealand Treasury methods.
    Boyd M; Mansoor OD; Baker MG; Wilson N
    Aust N Z J Public Health; 2018 Oct; 42(5):444-446. PubMed ID: 30088691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe illness from 2009 pandemic influenza A (H1N1)--Utah, 2009-10 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(38):1310-4. PubMed ID: 21956407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses - New Zealand, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(33):918-21. PubMed ID: 19713880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2009 pandemic influenza A (H1N1) in critically ill children in Cincinnati, Ohio.
    Morgan CI; Hobson MJ; Seger B; Rice MA; Staat MA; Wheeler DS
    Pediatr Crit Care Med; 2012 May; 13(3):e140-4. PubMed ID: 21760562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia.
    Ong MP; Sam IC; Azwa H; Mohd Zakaria IE; Kamarulzaman A; Wong MH; Syed Omar SF; Hussain SH
    J Infect; 2010 Nov; 61(5):440-2. PubMed ID: 20708031
    [No Abstract]   [Full Text] [Related]  

  • 28. Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England.
    Lau K; Hauck K; Miraldo M
    Health Econ; 2019 Feb; 28(2):175-188. PubMed ID: 30338588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The second winter of influenza A (H1N1) 2009 in Australian and New Zealand intensive care units.
    Seppelt IM; McArthur C; Webb SA
    Crit Care Resusc; 2010 Dec; 12(4):219-20. PubMed ID: 21143079
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study.
    Marbus SD; Schweitzer VA; Groeneveld GH; Oosterheert JJ; Schneeberger PM; van der Hoek W; van Dissel JT; van Gageldonk-Lafeber AB; Mangen MJ
    Eur J Health Econ; 2020 Jul; 21(5):775-785. PubMed ID: 32180069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness.
    Venkatesan S; Carias C; Biggerstaff M; Campbell AP; Nguyen-Van-Tam JS; Kahn E; Myles PR; Meltzer MI
    J Public Health (Oxf); 2019 Jun; 41(2):379-390. PubMed ID: 29955851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital costs of Bordetella pertussis in New Zealand children.
    Ganeshalingham A; Reed P; Grant C; Anderson B; Best E; Beca J
    N Z Med J; 2016 Nov; 129(1445):75-82. PubMed ID: 27857241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand?
    Tordoff JM; Norris PT; Reith DM
    Value Health; 2005; 8(3):201-8. PubMed ID: 15877592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
    Milne GJ; Halder N; Kelso JK
    PLoS One; 2013; 8(4):e61504. PubMed ID: 23585906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the economic impact of acute coronary syndrome in New Zealand over time (ANZACS-QI 64): a national registry-based cost burden study.
    Lee P; Kerr AJ; Jiang Y; Zomer E; Liew D
    BMJ Open; 2022 Aug; 12(8):e056405. PubMed ID: 35914917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical care services and the H1N1 (2009) influenza epidemic in Australia and New Zealand in 2010: the impact of the second winter epidemic.
    ; Webb SA; Aubron C; Bailey M; Bellomo R; Howe B; McArthur C; Morrison S; Seppelt I
    Crit Care; 2011 Jun; 15(3):R143. PubMed ID: 21658233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protecting an island nation from extreme pandemic threats: Proof-of-concept around border closure as an intervention.
    Boyd M; Baker MG; Mansoor OD; Kvizhinadze G; Wilson N
    PLoS One; 2017; 12(6):e0178732. PubMed ID: 28622344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic analysis of the use of facemasks during pandemic (H1N1) 2009.
    Tracht SM; Del Valle SY; Edwards BK
    J Theor Biol; 2012 May; 300():161-72. PubMed ID: 22300798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influenza pandemic of 1918-1919 in two remote island nations: Iceland and New Zealand.
    Summers JA; Wilson N; Baker MG; Gottfredsson M
    N Z Med J; 2013 Apr; 126(1373):74-80. PubMed ID: 23797079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pandemic influenza-implications for critical care resources in Australia and New Zealand.
    Anderson TA; Hart GK; Kainer MA;
    J Crit Care; 2003 Sep; 18(3):173-80. PubMed ID: 14595570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.